OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
JTH0.MU57

Gesundheitswelt Chiemgau AG

Healthcare Facilities & ServicesVerified

Gesundheitswelt Chiemgau AG maintains a liquidity position with a current ratio of 2.81, indicating the company can cover its short-term liabilities with its short-term assets. However, the company's free cash flow is negative at -2.88 million EUR, and capital expenditures are -7.60 million EUR, suggesting ongoing investment in operations. The company's cash and equivalents amount to 14.08 million EUR, but this is offset by long-term debt of 28.99 million EUR, resulting in a net cash position that is negative. In terms of profitability, the company's return on equity is 5.36%, and return on assets is 2.46%, both below the industry median for Healthcare Facilities & Services. The operating income of 3.93 million EUR and net income of 2.05 million EUR reflect a relatively modest profit margin, with gross profit at 66.80 million EUR. These figures suggest the company is generating returns but at a lower rate compared to industry peers. The company's geographic and segment exposure is concentrated in Germany, with all operations located in Bavaria. Revenue is derived from a mix of clinics and wellness facilities, including clinic St. Irmingard GmbH, Klinik ChiemseeWinkel Seebruck GmbH, and others. There is no disclosed segment breakdown, but the company's operations are primarily focused on healthcare services and wellness resorts. Looking at growth, the company's revenue for the latest period is 78.15 million EUR. While the outlook for the current fiscal year is not explicitly provided, the company's capital expenditures and negative free cash flow suggest a focus on maintaining and expanding its existing facilities. The company's long-term debt and capital structure indicate a moderate level of leverage, with a debt-to-equity ratio of 0.76. The company's risk assessment highlights a medium liquidity risk, with a key flag indicating that net cash is negative after subtracting total debt. The dilution risk is assessed as low, with no immediate pressure for share issuance. The company's capital structure and financial leverage suggest a moderate risk profile, but the negative free cash flow and capital expenditures indicate ongoing investment needs. Recent events and filings do not show any material changes in the company's operations or financial position. The company continues to operate its clinics and wellness facilities in Bavaria, with no significant new developments reported in the latest financial data.

30-day price · JTH0.MU-0.50 (-4.2%)
Low$11.00High$12.90Close$11.50As of15 May, 00:00 UTC
Profile
CompanyGesundheitswelt Chiemgau AG
TickerJTH0.MU
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryHealthcare Facilities & Services
AI analysis

Business. Gesundheitswelt Chiemgau AG operates sport facilities, leisure and wellness resorts, health resorts, and clinics in Bavaria, Germany, generating revenue through medical services, IT management, project management, and facility operations.

Classification. The company is classified under the Healthcare sector, specifically in the Healthcare Facilities & Services industry, with a confidence level of 0.92 based on verified market data.

Gesundheitswelt Chiemgau AG maintains a liquidity position with a current ratio of 2.81, indicating the company can cover its short-term liabilities with its short-term assets. However, the company's free cash flow is negative at -2.88 million EUR, and capital expenditures are -7.60 million EUR, suggesting ongoing investment in operations. The company's cash and equivalents amount to 14.08 million EUR, but this is offset by long-term debt of 28.99 million EUR, resulting in a net cash position that is negative. In terms of profitability, the company's return on equity is 5.36%, and return on assets is 2.46%, both below the industry median for Healthcare Facilities & Services. The operating income of 3.93 million EUR and net income of 2.05 million EUR reflect a relatively modest profit margin, with gross profit at 66.80 million EUR. These figures suggest the company is generating returns but at a lower rate compared to industry peers. The company's geographic and segment exposure is concentrated in Germany, with all operations located in Bavaria. Revenue is derived from a mix of clinics and wellness facilities, including clinic St. Irmingard GmbH, Klinik ChiemseeWinkel Seebruck GmbH, and others. There is no disclosed segment breakdown, but the company's operations are primarily focused on healthcare services and wellness resorts. Looking at growth, the company's revenue for the latest period is 78.15 million EUR. While the outlook for the current fiscal year is not explicitly provided, the company's capital expenditures and negative free cash flow suggest a focus on maintaining and expanding its existing facilities. The company's long-term debt and capital structure indicate a moderate level of leverage, with a debt-to-equity ratio of 0.76. The company's risk assessment highlights a medium liquidity risk, with a key flag indicating that net cash is negative after subtracting total debt. The dilution risk is assessed as low, with no immediate pressure for share issuance. The company's capital structure and financial leverage suggest a moderate risk profile, but the negative free cash flow and capital expenditures indicate ongoing investment needs. Recent events and filings do not show any material changes in the company's operations or financial position. The company continues to operate its clinics and wellness facilities in Bavaria, with no significant new developments reported in the latest financial data.
Key takeaways
  • Gesundheitswelt Chiemgau AG operates in the Healthcare Facilities & Services industry with a focus on wellness and medical services in Bavaria.
  • The company's liquidity position is moderate, with a current ratio of 2.81 but negative free cash flow and capital expenditures.
  • Profitability metrics such as return on equity and return on assets are below industry medians, indicating lower efficiency in generating returns.
  • The company's operations are concentrated in Germany, with no disclosed segment breakdown.
  • The company's risk profile is moderate, with medium liquidity risk and low dilution risk.
  • The company's capital expenditures suggest ongoing investment in its facilities and operations.
  • --
  • ## RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyEUR
Revenue$78.2M
Gross profit$66.8M
Operating income$3.9M
Net income$2.0M
R&D
SG&A
D&A
SBC
Operating cash flow$4.6M
CapEx-$7.6M
Free cash flow-$2.9M
Total assets$83.3M
Total liabilities$45.2M
Total equity$38.2M
Cash & equivalents$14.1M
Long-term debt$29.0M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$38.2M
Net cash-$14.9M
Current ratio2.8
Debt/Equity0.8
ROA2.5%
ROE5.4%
Cash conversion2.3%
CapEx/Revenue-9.7%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Biotechnology · cohort 9 companies
MetricJTH0.MUActivity
Op margin5.0%11.5% medp25 9.9% · p75 15.0%bottom quartile
Net margin2.6%8.6% medp25 6.3% · p75 12.4%bottom quartile
Gross margin85.5%28.8% medp25 28.8% · p75 28.8%top quartile
CapEx / revenue-9.7%4.2% medp25 3.8% · p75 4.2%bottom quartile
Debt / equity76.0%71.3% medp25 60.7% · p75 71.3%top quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-07 23:48 UTC#4900a06e
Source: analysis-pipeline (hybrid)Generated: 2026-05-03 18:05 UTCJob: 0fbb98a2